NCT01443741

Brief Summary

Evaluation of interests of the functional insulin therapy (FIT Therapy) on metabolic control, hypoglycemia prevention and life quality of diabetics children insulin-dependent treated with insulin pump.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
88

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Jan 2012

Typical duration for phase_2

Geographic Reach
1 country

6 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 30, 2011

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

September 30, 2011

Status Verified

September 1, 2011

Enrollment Period

3 years

First QC Date

September 28, 2011

Last Update Submit

September 28, 2011

Conditions

Keywords

FIT TherapyDiabetes mellitusInsulin pumpPediatric

Outcome Measures

Primary Outcomes (1)

  • Variation in HbA1c

    Variation in HbA1c from baseline in the study (M0) and 1 year later the beginning of the program (M12) for assess the importance of the FIT Therapy to improve metabolic control of children with diabetes mellitus treated with subcutaneous insulin pump.

    One year

Secondary Outcomes (1)

  • Severe hypoglycemia over 6 months and quality of life

    One year and six months

Study Arms (2)

FIT Therapy

ACTIVE COMPARATOR

Patient with functional insulin therapy

Other: Therapeutic education

Traditional way

ACTIVE COMPARATOR

Patient with traditional way

Other: Therapeutic education

Interventions

Specific program for FIT Therapy and specific program for traditional way

Also known as: Functional insulin therapy, Traditional way (fixed doses of insulin)
FIT TherapyTraditional way

Eligibility Criteria

Age1 Year - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • aged 1-17 years
  • diabetic for at least 1 year
  • whose HbA1c is between 7.6 and 10% (7.6% \<HbA1C \<10%)
  • treated with insulin pump
  • agreeing to perform at least three blood glucose/day
  • willing to follow the treatment with functional insulin therapy if necessary

You may not qualify if:

  • Ages \<1 year or\> 17 years
  • Duration of diabetes \<1 year
  • HbA1c \<7.6% or HbA1c\> 10%
  • Treatment-by multiple injections
  • Mental disability
  • Refusal to adhere to the constraints of the study
  • Language barrier, preventing any understanding or cooperation
  • Eating behavior-type anorexia or bulimia
  • Pregnancy
  • Use of alcohol or drugs
  • Severe chronic or genetic pathology other than diabetes
  • Participation in another clinical study or refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

University Hospital of Lyon

Lyon, Auvergne-Rhône-Alpes, 69000, France

Location

University Hospital of Brest

Brest, Brittany Region, 29200, France

Location

University Hospital of Tours

Tours, Centre-Val de Loire, 37000, France

Location

University Hospital of Toulouse

Toulouse, Midi-Pyrénées, 31059, France

Location

University Hospital of Angers Service of Pediatric Diabetology and Endocrinology

Angers, Pays de Loire, 49933, France

Location

University Hospital of Nantes

Nantes, Pays de Loire, 44093, France

Location

Related Publications (5)

  • Langewitz W, Wossmer B, Iseli J, Berger W. Psychological and metabolic improvement after an outpatient teaching program for functional intensified insulin therapy (FIT). Diabetes Res Clin Pract. 1997 Sep;37(3):157-64. doi: 10.1016/s0168-8227(97)00071-5.

    PMID: 9306036BACKGROUND
  • Hartemann-Heurtier A, Sachon C, Masseboeuf N, Corset E, Grimaldi A. Functional intensified insulin therapy with short-acting insulin analog: effects on HbA1c and frequency of severe hypoglycemia. An observational cohort study. Diabetes Metab. 2003 Feb;29(1):53-7. doi: 10.1016/s1262-3636(07)70007-1.

    PMID: 12629448BACKGROUND
  • Samann A, Muhlhauser I, Bender R, Kloos Ch, Muller UA. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia. 2005 Oct;48(10):1965-70. doi: 10.1007/s00125-005-1905-1. Epub 2005 Aug 18.

    PMID: 16132954BACKGROUND
  • Lowe J, Linjawi S, Mensch M, James K, Attia J. Flexible eating and flexible insulin dosing in patients with diabetes: Results of an intensive self-management course. Diabetes Res Clin Pract. 2008 Jun;80(3):439-43. doi: 10.1016/j.diabres.2008.02.003. Epub 2008 Mar 18.

    PMID: 18353485BACKGROUND
  • Grimm JJ, Ybarra J, Berne C, Muchnick S, Golay A. A new table for prevention of hypoglycaemia during physical activity in type 1 diabetic patients. Diabetes Metab. 2004 Nov;30(5):465-70. doi: 10.1016/s1262-3636(07)70144-1.

    PMID: 15671916BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Régis Coutant, MD PhD

    UH Angers

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Régis Coutant, MD PhD

CONTACT

Natacha Bouhours-Nouet, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2011

First Posted

September 30, 2011

Study Start

January 1, 2012

Primary Completion

January 1, 2015

Study Completion

July 1, 2015

Last Updated

September 30, 2011

Record last verified: 2011-09

Locations